proxyvotesnow.com

Home › Companies › IMMUNOCORE HOLDINGS PLC › 2024-2025

IMMUNOCORE HOLDINGS PLC 2024-2025 Proxy Voting Records

Compiled from SEC Form N-PX filings and IMMUNOCORE HOLDINGS PLC’s Form 8-K, filed 2025-05-15 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 15Reported items
  • 118Asset managers
  • 997Fund votes
  • 2025-05-15Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore IMMUNOCORE HOLDINGS PLC in the interactive database Compare manager voting policies

Official 2024-2025 meeting results reported by IMMUNOCORE HOLDINGS PLC

These tallies are IMMUNOCORE HOLDINGS PLC’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2025-05-15 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

IMMUNOCORE HOLDINGS PLC — official shareholder meeting results, meeting held 2025-05-15
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Resolution 2 : To re-appoint as a director of the Company Ranjeev Krishana. 32,271,306472,0253,089 ---- Majority: yes
Resolution 3 : To re-appoint as a director of the Company Professor Sir Peter Ratcliffe. 30,325,6732,417,6583,089 ---- Majority: yes
Resolution 4: To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement. 27,835,0464,908,0153,359 ---- Majority: yes
Resolution 5: To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending December 31, 2025. 32,742,1561,5282,736 ---- Majority: yes
Resolution 6 : To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general meeting of shareholders 32,742,1751,4992,746 ---- Majority: yes
Resolution 7 : To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending December 31, 2025. 32,741,5792,1052,736 ---- Majority: yes
Resolution 8 : To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2024 (the "2024 U.K. 32,741,6471,4963,277 ---- Majority: yes
Resolution 9 : To approve the directors' remuneration report for the year ended December 31, 2024, which is set forth as Annex A to the Proxy Statement and on pages 22 to 49 of the 2024 U.K. Annual Report (excluding the directors' remunerat 27,889,9304,853,1063,384 ---- Majority: yes
Resolution 10 : To approve the directors' remuneration policy, which is set forth on pages A-5 to A-15 of Annex A to the Proxy Statement. 27,915,1274,827,9053,388 ---- Majority: yes
Resolution 11 : To authorize the Company to make political donations/incur political expenditure. 32,687,7655,74152,914 ---- Majority: yes
Resolution 12 : To authorize the directors of the Company to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of £150,000 for a period ex 27,948,8844,793,1774,359 ---- Majority: yes
Special Resolution Resolution 13 : To empower the directors of the Company to allot equity securities for cash pursuant to the general authority conferred on them by resolution 12. 27,949,5634,792,7944,063 ---- Majority: yes

Source: IMMUNOCORE HOLDINGS PLC, Form 8-K, filed with the SEC on 2025-05-15 — read the filing on EDGAR.

How asset managers voted at the IMMUNOCORE HOLDINGS PLC 2024-2025 meeting

Each item below shows how the 118 asset managers that disclosed a IMMUNOCORE HOLDINGS PLC vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of IMMUNOCORE HOLDINGS PLC’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 9 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%AGAINST 15%
FOR: 27,835,046AGAINST: 4,908,015

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 4: To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.”): 27,835,046 for, 4,908,015 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,233,609 outstanding shares: 55% for, 10% against (65% of the company cast a for/against vote).

The 117 asset managers below cast 86% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 86%14%
FOR: 86.3%AGAINST: 13.6%ABSTAIN: 0.0%
Largest asset managers voting on “To approve, on advisory basis, the compensation of the Company's named executive officers, as disclosed in the” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price9,086,0963,306,742 00For
Fidelity8,014,62335,520 00For
Vanguard6,114,5941,700 00For
Wellington5,492,6860 00For
PRIMECAP MANAGEMENT CO/CA/2,650,4800 00For
BAKER BROS. ADVISORS LP2,322,6560 00For
RTW INVESTMENTS, LP2,117,5430 00For
Deep Track Capital, LP1,290,4530 00For
PRIMECAP Odyssey Funds748,4300 00For
Fiera Capital Corp0742,348 00Against
ARMISTICE CAPITAL, LLC566,1250 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/454,7430 00For
MFS402,4000 00For
Frazier Life Sciences Management, L.P.384,7820 00For
Point720380,571 00Against
Woodline Partners LP326,9920 00For
Two Sigma0297,748 00Against
PRINCIPAL GLOBAL INVESTORS0278,580 00Against
Principal0201,762 00Against
BNP Paribas Asset Management Holding S.A.0161,292 00Against
Hudson Bay Capital Management LP0143,958 00Against
Candriam S.C.A.0134,779 00Against
AXA INVESTMENT MANAGERS UK Ltd094,762 00Against
New York Life093,279 00Against
Pacific Life80,7950 00For

Showing the 25 largest of 117 asset managers. See all 117 in the interactive database.

2. To approve the directors' remuneration policy, which is set forth on pages A-5 to A-15 of Annex A to the proxy statement, which will take effect immediately after the end of the AGM.

COMPENSATION

Combines 2 wordings of this item as funds reported it.

84% fund support · no official result

FOR 84%AGAINST 16%

The 32 asset managers below cast 84% of the shares they voted on this item FOR (13,962,411 for, 2,689,889 against).

FOR: 13,962,411 (83.8%)AGAINST: 2,689,889 (16.1%)ABSTAIN: 3,577 (0.0%)
Largest asset managers voting on “To approve the directors' remuneration policy, which is set forth on pages A-5 to A-15 of Annex A to the proxy” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price3,188,2311,502,755 00For
Fidelity3,178,32535,520 00For
PRIMECAP Odyssey Funds748,4300 00For
Fiera Capital Corp0742,348 00Against
MFS402,4000 00For
Principal0201,762 00Against
New York Life093,273 00Against
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock60,478174 00For
STEWARD FUNDS, INC.037,465 00Against
John Hancock17628,922 00Against
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC010,567 00Against
OLD WESTBURY FUNDS INC09,366 00Against
Goldman Sachs07,524 00Against
Blackstone Alternative Investment Funds06,500 00Against
ETF Series Solutions04,770 00Against
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust03,590 00Against
Brighthouse00 2,5250Abstain

Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.

3. To authorize the directors to allot shares or to grant rights to subscribe for or convert any security into shares up to an aggregate nominal amount of pounds150,000.

CAPITAL STRUCTUREMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%AGAINST 15%
FOR: 27,948,884AGAINST: 4,793,177

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 12 : To authorize the directors of the Company to allot shares in the Company or to grant rights to subscribe for or to convert any security into shares in the Company up to an aggregate nominal amount of £150”): 27,948,884 for, 4,793,177 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,233,609 outstanding shares: 56% for, 10% against (65% of the company cast a for/against vote).

The 31 asset managers below cast 88% of the shares they voted on this item FOR (13,938,990 for, 1,954,106 against).

FOR 83%12%
FOR: 13,938,990 (83.3%)AGAINST: 1,954,106 (11.7%)ABSTAIN: 834,479 (5.0%)
Largest asset managers voting on “To authorize the directors to allot shares or to grant rights to subscribe for or convert any security into sh” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price3,188,2311,502,755 00For
Fidelity3,178,32535,520 00For
Kynam Capital Management, LP00 834,4790Abstain
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal0201,762 00Against
New York Life093,273 00Against
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.037,465 00Against
John Hancock17628,922 00Against
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC010,567 00Against
OLD WESTBURY FUNDS INC09,366 00Against
Goldman Sachs07,524 00Against
Blackstone Alternative Investment Funds06,500 00Against
ETF Series Solutions04,770 00Against
State Street04,214 00Against
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust03,590 00Against
Brighthouse02,525 00Against

Showing the 25 largest of 31 asset managers. See all 31 in the interactive database.

4. To authorize the Company to make political donations/incur political expenditure.

OTHER SOCIAL ISSUESMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 32,687,765AGAINST: 5,741

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 11 : To authorize the Company to make political donations/incur political expenditure.”): 32,687,765 for, 5,741 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,233,609 outstanding shares: 65% for, 0.1% against (65% of the company cast a for/against vote).

The 30 asset managers below cast 100% of the shares they voted on this item FOR (15,890,571 for, 0 against).

FOR 99.9%
FOR: 15,890,571 (100.0%)ABSTAIN: 2,525 (0.0%)
Largest asset managers voting on “To authorize the Company to make political donations/incur political expenditure.” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price4,690,9860 00For
Fidelity3,213,8450 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal201,7620 00For
New York Life93,2730 00For
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.37,4650 00For
John Hancock29,0980 00For
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC10,5670 00For
OLD WESTBURY FUNDS INC9,3660 00For
Goldman Sachs7,5240 00For
Blackstone Alternative Investment Funds6,5000 00For
ETF Series Solutions4,7700 00For
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust3,5900 00For
Brighthouse00 2,5250Abstain
Equitable1,8080 00For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

5. To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending 31 December 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 32,741,579AGAINST: 2,105

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 7 : To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending December 31, 2025.”): 32,741,579 for, 2,105 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,233,609 outstanding shares: 65% for, 0.1% against (65% of the company cast a for/against vote).

The 30 asset managers below cast 100% of the shares they voted on this item FOR (15,890,571 for, 0 against).

FOR 99.9%
FOR: 15,890,571 (100.0%)ABSTAIN: 2,525 (0.0%)
Largest asset managers voting on “To authorize the audit committee to determine the U.K. statutory auditors' remuneration for the year ending 31” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price4,690,9860 00For
Fidelity3,213,8450 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal201,7620 00For
New York Life93,2730 00For
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.37,4650 00For
John Hancock29,0980 00For
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC10,5670 00For
OLD WESTBURY FUNDS INC9,3660 00For
Goldman Sachs7,5240 00For
Blackstone Alternative Investment Funds6,5000 00For
ETF Series Solutions4,7700 00For
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust3,5900 00For
Brighthouse00 2,5250Abstain
Equitable1,8080 00For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

6. To empower the directors to allot equity securities for cash pursuant to the authorization in resolution 12 as if U.K. statutory pre-emption rights did not apply.

CAPITAL STRUCTUREMajority of the votes cast: yes

85% Majority: yes · of votes cast

FOR 85%AGAINST 15%
FOR: 27,949,563AGAINST: 4,792,794

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Special Resolution Resolution 13 : To empower the directors of the Company to allot equity securities for cash pursuant to the general authority conferred on them by resolution 12.”): 27,949,563 for, 4,792,794 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,233,609 outstanding shares: 56% for, 10% against (65% of the company cast a for/against vote).

The 30 asset managers below cast 88% of the shares they voted on this item FOR (13,938,990 for, 1,954,106 against).

FOR 88%12%
FOR: 13,938,990 (87.7%)AGAINST: 1,954,106 (12.3%)
Largest asset managers voting on “To empower the directors to allot equity securities for cash pursuant to the authorization in resolution 12 as” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price3,188,2311,502,755 00For
Fidelity3,178,32535,520 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal0201,762 00Against
New York Life093,273 00Against
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.037,465 00Against
John Hancock17628,922 00Against
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC010,567 00Against
OLD WESTBURY FUNDS INC09,366 00Against
Goldman Sachs07,524 00Against
Blackstone Alternative Investment Funds06,500 00Against
ETF Series Solutions04,770 00Against
State Street04,214 00Against
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust03,590 00Against
Brighthouse02,525 00Against
Equitable01,808 00Against

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

7. To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.S. independent registered public accounting firm for the year ending 31 December 2025.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 32,742,156AGAINST: 1,528

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 5: To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.S. independent registered public accounting firm for the year ending Decemb”): 32,742,156 for, 1,528 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,233,609 outstanding shares: 65% for, 0.1% against (65% of the company cast a for/against vote).

The 30 asset managers below cast 100% of the shares they voted on this item FOR (15,890,571 for, 0 against).

FOR 99.9%
FOR: 15,890,571 (100.0%)ABSTAIN: 2,525 (0.0%)
Largest asset managers voting on “To ratify the appointment of Deloitte LLP, a limited liability partnership organized under the laws of England” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price4,690,9860 00For
Fidelity3,213,8450 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal201,7620 00For
New York Life93,2730 00For
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.37,4650 00For
John Hancock29,0980 00For
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC10,5670 00For
OLD WESTBURY FUNDS INC9,3660 00For
Goldman Sachs7,5240 00For
Blackstone Alternative Investment Funds6,5000 00For
ETF Series Solutions4,7700 00For
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust3,5900 00For
Brighthouse00 2,5250Abstain
Equitable1,8080 00For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

8. To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. statutory auditors, to hold office until the conclusion of our next annual general meeting of shareholders.

AUDIT-RELATEDMajority of the votes cast: yes

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 32,742,175AGAINST: 1,499

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 6 : To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as the Company's U.K. statutory auditors, to hold office until the conclusion of the next annual general mee”): 32,742,175 for, 1,499 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,233,609 outstanding shares: 65% for, 0.1% against (65% of the company cast a for/against vote).

The 30 asset managers below cast 100% of the shares they voted on this item FOR (15,890,571 for, 0 against).

FOR 99.9%
FOR: 15,890,571 (100.0%)ABSTAIN: 2,525 (0.0%)
Largest asset managers voting on “To re-appoint Deloitte LLP, a limited liability partnership organized under the laws of England, as our U.K. s” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price4,690,9860 00For
Fidelity3,213,8450 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal201,7620 00For
New York Life93,2730 00For
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.37,4650 00For
John Hancock29,0980 00For
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC10,5670 00For
OLD WESTBURY FUNDS INC9,3660 00For
Goldman Sachs7,5240 00For
Blackstone Alternative Investment Funds6,5000 00For
ETF Series Solutions4,7700 00For
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust3,5900 00For
Brighthouse00 2,5250Abstain
Equitable1,8080 00For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

9. To re-appoint as a director Professor Sir Peter Ratcliffe, who retires in accordance with the articles of association.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

93% Majority: yes · of votes cast

FOR 93%7%
FOR: 30,325,673AGAINST: 2,417,658

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 3 : To re-appoint as a director of the Company Professor Sir Peter Ratcliffe.”): 30,325,673 for, 2,417,658 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,233,609 outstanding shares: 60% for, 5% against (65% of the company cast a for/against vote).

The 30 asset managers below cast 95% of the shares they voted on this item FOR (15,150,739 for, 739,832 against).

FOR 95%
FOR: 15,150,739 (95.3%)AGAINST: 739,832 (4.7%)ABSTAIN: 2,525 (0.0%)
Largest asset managers voting on “To re-appoint as a director Professor Sir Peter Ratcliffe, who retires in accordance with the articles of asso” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price4,690,9860 00For
Fidelity3,213,8450 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS0402,400 00Against
Principal0201,762 00Against
New York Life93,2730 00For
Pacific Life28,45252,343 00Against
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.037,465 00Against
John Hancock29,0980 00For
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC010,567 00Against
OLD WESTBURY FUNDS INC09,366 00Against
Goldman Sachs07,524 00Against
Blackstone Alternative Investment Funds06,500 00Against
ETF Series Solutions04,770 00Against
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust03,590 00Against
Brighthouse00 2,5250Abstain
Equitable1,8080 00For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

10. To re-appoint as a director Ranjeev Krishana, who retires in accordance with the articles of association.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 32,271,306AGAINST: 472,025

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 2 : To re-appoint as a director of the Company Ranjeev Krishana.”): 32,271,306 for, 472,025 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,233,609 outstanding shares: 64% for, 1.0% against (65% of the company cast a for/against vote).

The 30 asset managers below cast 100% of the shares they voted on this item FOR (15,890,571 for, 0 against).

FOR 99.9%
FOR: 15,890,571 (100.0%)ABSTAIN: 2,525 (0.0%)
Largest asset managers voting on “To re-appoint as a director Ranjeev Krishana, who retires in accordance with the articles of association.” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price4,690,9860 00For
Fidelity3,213,8450 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal201,7620 00For
New York Life93,2730 00For
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.37,4650 00For
John Hancock29,0980 00For
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC10,5670 00For
OLD WESTBURY FUNDS INC9,3660 00For
Goldman Sachs7,5240 00For
Blackstone Alternative Investment Funds6,5000 00For
ETF Series Solutions4,7700 00For
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust3,5900 00For
Brighthouse00 2,5250Abstain
Equitable1,8080 00For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

11. To re-appoint as a director Roy S. Herbst, M.D., Ph.D., who retires in accordance with the articles of association.

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

36% fund support · no official result

FOR 36%AGAINST 64%

The 30 asset managers below cast 36% of the shares they voted on this item FOR (5,761,889 for, 10,128,682 against).

FOR: 5,761,889 (36.3%)AGAINST: 10,128,682 (63.7%)ABSTAIN: 2,525 (0.0%)
Largest asset managers voting on “To re-appoint as a director Roy S. Herbst, M.D., Ph.D., who retires in accordance with the articles of associa” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard1,756,3904,358,204 00Against
T. Rowe Price3,188,2311,502,755 00For
Fidelity03,213,845 00Against
PRIMECAP Odyssey Funds748,4300 00For
MFS0402,400 00Against
Principal0201,762 00Against
New York Life093,273 00Against
Pacific Life080,795 00Against
Northwestern Mutual68,5590 00For
Hartford068,221 00Against
BlackRock041,271 00Against
STEWARD FUNDS, INC.037,465 00Against
John Hancock17628,922 00Against
Nationwide027,930 00Against
Tema ETF Trust015,428 00Against
PRINCIPAL VARIABLE CONTRACTS FUNDS INC010,567 00Against
OLD WESTBURY FUNDS INC09,366 00Against
Goldman Sachs07,524 00Against
Blackstone Alternative Investment Funds06,500 00Against
ETF Series Solutions04,770 00Against
State Street04,214 00Against
Guardian Variable Products Trust03,803 00Against
ALPS ETF Trust03,590 00Against
Brighthouse00 2,5250Abstain
Equitable01,808 00Against

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

12. To receive and adopt the U.K. statutory annual accounts and reports for the year ended 31 December 2024.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Combines 2 wordings of this item as funds reported it.

99.9% Majority: yes · of votes cast

FOR 99.9%
FOR: 32,741,647AGAINST: 1,496

IMMUNOCORE HOLDINGS PLC’s own tally for this item (“Resolution 8 : To receive and adopt the U.K. statutory annual accounts and reports for the year ended December 31, 2024 (the "2024 U.K.”): 32,741,647 for, 1,496 against, per its Form 8-K filed 2025-05-15 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 50,233,609 outstanding shares: 65% for, 0.1% against (65% of the company cast a for/against vote).

The 30 asset managers below cast 100% of the shares they voted on this item FOR (15,890,571 for, 0 against).

FOR 99.9%
FOR: 15,890,571 (100.0%)ABSTAIN: 2,525 (0.0%)
Largest asset managers voting on “To receive and adopt the U.K. statutory annual accounts and reports for the year ended 31 December 2024.” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
T. Rowe Price4,690,9860 00For
Fidelity3,213,8450 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal201,7620 00For
New York Life93,2730 00For
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
Hartford68,2210 00For
BlackRock41,2710 00For
STEWARD FUNDS, INC.37,4650 00For
John Hancock29,0980 00For
Nationwide27,9300 00For
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC10,5670 00For
OLD WESTBURY FUNDS INC9,3660 00For
Goldman Sachs7,5240 00For
Blackstone Alternative Investment Funds6,5000 00For
ETF Series Solutions4,7700 00For
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust3,5900 00For
Brighthouse00 2,5250Abstain
Equitable1,8080 00For

Showing the 25 largest of 30 asset managers. See all 30 in the interactive database.

13. To approve the directors' remuneration report FOR the year ended 31 December 2024, which is set FORth as Annex A to the proxy statement (excluding the directors' remuneration policy set out on pages A-5 to A-15 of Annex A to the proxy statement).

COMPENSATION

Combines 2 wordings of this item as funds reported it.

80% fund support · no official result

FOR 80%AGAINST 20%

The 27 asset managers below cast 80% of the shares they voted on this item FOR (7,751,042 for, 1,948,478 against).

FOR: 7,751,042 (79.9%)AGAINST: 1,948,478 (20.1%)
Largest asset managers voting on “To approve the directors' remuneration report FOR the year ended 31 December 2024, which is set FORth as Annex” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
T. Rowe Price3,188,2311,502,755 00For
Fidelity3,178,32535,520 00For
PRIMECAP Odyssey Funds748,4300 00For
MFS402,4000 00For
Principal0201,762 00Against
New York Life093,273 00Against
Pacific Life80,7950 00For
Northwestern Mutual68,5590 00For
BlackRock60,478174 00For
STEWARD FUNDS, INC.037,465 00Against
John Hancock17628,922 00Against
Tema ETF Trust15,4280 00For
PRINCIPAL VARIABLE CONTRACTS FUNDS INC010,567 00Against
OLD WESTBURY FUNDS INC09,366 00Against
Goldman Sachs07,524 00Against
Blackstone Alternative Investment Funds06,500 00Against
ETF Series Solutions04,770 00Against
State Street4,2140 00For
Guardian Variable Products Trust3,8030 00For
ALPS ETF Trust03,590 00Against
Equitable01,808 00Against
AIG/SunAmerica01,800 00Against
ProShares01,712 00Against
Vident Advisory, LLC0937 00Against
MassMutual1030 00For

Showing the 25 largest of 27 asset managers. See all 27 in the interactive database.

14. To approve our directors remuneration report for the year ended December 31, 2024, which is set forth as Annex A to the proxy statement and on pages 22 to 49 of the 2024 U.K. Annual Report (excluding the directors remuneration policy set out on pages A-5 to A-15 of Annex A).

SECTION 14A SAY-ON-PAY VOTES

Combines 5 wordings of this item as funds reported it.

0.1% fund support · no official result

AGAINST 47.1%ABSTAIN 52.9%

The 7 asset managers below cast 0.1% of the shares they voted on this item FOR (127 for, 743,334 against).

FOR: 127 (0.0%)AGAINST: 743,334 (47.1%)ABSTAIN: 835,531 (52.9%)
Largest asset managers voting on “To approve our directors remuneration report for the year ended December 31, 2024, which is set forth as Annex” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Kynam Capital Management, LP00 834,4790Abstain
Fiera Capital Corp0742,348 00Against
ELEVATION POINT WEALTH PARTNERS, LLC00 1,0520Abstain
Haverford Trust Co0625 00Against
HANCOCK WHITNEY CORP0266 00Against
Savant Capital, LLC1270 00For
Argent Trust Co095 00Against

15. To approve our directors' remuneration report for the year ended December 31, 2024, which is set forth as Annex A to the proxy statement (excluding the directors' remuneration policy set out on pages A-5 to A-15 of Annex A to the proxy statement).

COMPENSATION

100% fund support · no official result

FOR 99.9%

The 5 asset managers below cast 100% of the shares they voted on this item FOR (6,211,469 for, 0 against).

FOR: 6,211,469 (100.0%)ABSTAIN: 2,525 (0.0%)
Largest asset managers voting on “To approve our directors' remuneration report for the year ended December 31, 2024, which is set forth as Anne” at IMMUNOCORE HOLDINGS PLC, 2024-2025
Asset managerForAgainst AbstainWithheldVote
Vanguard6,114,5940 00For
Hartford68,2210 00For
Nationwide27,9300 00For
Brighthouse00 2,5250Abstain
Victory Capital7240 00For

Largest IMMUNOCORE HOLDINGS PLC shareholders voting in 2024-2025

Ranked by the number of IMMUNOCORE HOLDINGS PLC shares each manager voted on the most widely held ballot item of the 2024-2025 meeting, shown as a share of the 50,233,609 shares outstanding at the time of that meeting.

Top IMMUNOCORE HOLDINGS PLC shareholders by shares voted, 2024-2025
#Asset manager % of shares outstanding
1T. Rowe Price 24.67%
2Fidelity 16.03%
3Vanguard 12.18%
4Wellington 10.93%
5PRIMECAP MANAGEMENT CO/CA/ 5.28%
6BAKER BROS. ADVISORS LP 4.62%
7RTW INVESTMENTS, LP 4.22%
8Deep Track Capital, LP 2.57%
9PRIMECAP Odyssey Funds 1.49%
10Fiera Capital Corp 1.48%

Reported IMMUNOCORE HOLDINGS PLC ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

IMMUNOCORE HOLDINGS PLC beneficial owners on record for the 2024-2025 proxy season
Holder % outstanding Disclosure
Wellington Management 12.21% 13F
Entities affiliated with RTW 9.69% DEF14A
FMR (Fidelity) 9.64% 13F
Bahija Jallal, Ph.D. 9.07% DEF14A
Jallal Bahija 8.94% 13G
Entities affiliated with FMR LLC 8.73% DEF14A
PRIMECAP MANAGEMENT CO/CA/ 7.51% 13G
Bellevue Group AG 5.57% 13G
Vestal Point Capital, LP 5.51% 13G
TANG CAPITAL MANAGEMENT, LLC 5.19% 13G

Percentages above are of 50,233,609 shares outstanding, as reported by IMMUNOCORE HOLDINGS PLC on its Form 10-Q dated 2025-04-30 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IMMUNOCORE HOLDINGS PLC’s 10-Q dated 2025-04-30. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At IMMUNOCORE HOLDINGS PLC's shareholder meeting held 2025-05-15, in the 2024-2025 proxy season, 118 asset managers reported how they voted in their SEC Form N-PX filings, covering 997 separate fund positions. Their filings are grouped here into 15 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on advisory basis, the compensation of the Company's named executive officers, as… — FOR was 85% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: IMMUNOCORE HOLDINGS PLC's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2025-05-15.

IMMUNOCORE HOLDINGS PLC proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.